|
|
| Download available for users with full-size access enabled |
|
RisperdalConsta - solid footing
|
For many patients with schizophrenia
Gaps in medication can compromise their progress
The only long-acting atypical antipsychotic
In schizophrenia
Help to keep them on solid footing-two weeks at a time
Risperdal Consta, while not guaranteed adherence, allows you to recognize and intervene when a patient misses a dose
Campaign files
Similar ads
Brand name: RisperdalConsta
Generic name/category: risperidone
Company: Janssen
Country/Market: USA, North America
Indication(s)/Category: schizophrenia
Target: Healthcare Professionals (HCP)
Tagline: none
Medium: Print ad
Size/duration: Double-page spread
Publication/Aired: Psychiatric News - January 18, 2008
To see more of this brand's ads, click here |
|